SCHEMBL18878131

SCHEMBL18878131

C=COCCC(C)(C)OCCC(C)(C)OC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27617201 0.92
SCHEMBL20124724 0.82
SCHEMBL15483565 0.78
SCHEMBL21496040 0.77
SCHEMBL18400492 0.75 TSHR (0.43)
SCHEMBL896003 0.75
SCHEMBL20204610 0.74
SCHEMBL19706262 0.72
SCHEMBL21609228 0.72
SCHEMBL20459917 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10655004-B2 Electrochemical sensor system ASCENSIA DIABETES CARE HOLDINGS AG (CH) 2020-05-19 US disclosed
US-10647846-B2 Electrochemical sensor system ASCENSIA DIABETES CARE HOLDINGS AG (CH) 2020-05-12 US disclosed
US-20190136038-A1 Electrochemical Sensor System BAYER HEALTHCARE LLC 2019-05-09 US disclosed
US-20190136037-A1 Electrochemical Sensor System BAYER HEALTHCARE LLC 2019-05-09 US disclosed
US-10227485-B2 Electrochemical sensor system Ascensia Diabetics Care Holdings AG (CH) 2019-03-12 US disclosed
US-10196512-B2 Method of determining an analyte concentration ASCENSIA DIABETES CARE HOLDINGS AG (CH) 2019-02-05 US disclosed
US-20170145203-A1 HYDROGEL COMPOSITION BAYER HEALTHCARE LLC 2017-05-25 US disclosed